Falak A. Siddiqui

705 total citations
28 papers, 487 citations indexed

About

Falak A. Siddiqui is a scholar working on Organic Chemistry, Computational Theory and Mathematics and Complementary and alternative medicine. According to data from OpenAlex, Falak A. Siddiqui has authored 28 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 6 papers in Computational Theory and Mathematics and 5 papers in Complementary and alternative medicine. Recurrent topics in Falak A. Siddiqui's work include Synthesis and biological activity (8 papers), Computational Drug Discovery Methods (6 papers) and Synthesis and Biological Evaluation (4 papers). Falak A. Siddiqui is often cited by papers focused on Synthesis and biological activity (8 papers), Computational Drug Discovery Methods (6 papers) and Synthesis and Biological Evaluation (4 papers). Falak A. Siddiqui collaborates with scholars based in India, Saudi Arabia and Bangladesh. Falak A. Siddiqui's co-authors include Sharuk L. Khan, Nitin Nema, Fahadul Islam, Mayura Kale, Talha Bin Emran, Neha Chauhan, Hitesh Chopra, Mehrukh Zehravi, Rajendra Marathe and Siddharth Jain and has published in prestigious journals such as Molecules, Progress in Biophysics and Molecular Biology and Frontiers in Cell and Developmental Biology.

In The Last Decade

Falak A. Siddiqui

26 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Falak A. Siddiqui India 13 131 114 112 67 62 28 487
Sharuk L. Khan India 16 165 1.3× 135 1.2× 163 1.5× 86 1.3× 68 1.1× 45 645
Weerasak Samee Thailand 13 150 1.1× 22 0.2× 93 0.8× 38 0.6× 54 0.9× 37 513
Sivakumar Annadurai Saudi Arabia 13 113 0.9× 28 0.2× 217 1.9× 23 0.3× 31 0.5× 28 669
Tarun Virmani India 16 35 0.3× 43 0.4× 158 1.4× 26 0.4× 116 1.9× 54 619
Vuyolwethu Khwaza South Africa 10 100 0.8× 22 0.2× 276 2.5× 26 0.4× 15 0.2× 18 556
Ambreen Shoaib Saudi Arabia 17 50 0.4× 56 0.5× 220 2.0× 26 0.4× 27 0.4× 41 663
Durgacharan A. Bhagwat India 13 33 0.3× 45 0.4× 112 1.0× 16 0.2× 151 2.4× 40 499
Neila Márcia Silva-Barcellos Brazil 13 58 0.4× 29 0.3× 106 0.9× 10 0.1× 51 0.8× 28 513
Nabeela Ameer Pakistan 9 50 0.4× 31 0.3× 93 0.8× 15 0.2× 61 1.0× 23 407
Neetesh Kumar Jain India 11 35 0.3× 21 0.2× 86 0.8× 39 0.6× 109 1.8× 43 352

Countries citing papers authored by Falak A. Siddiqui

Since Specialization
Citations

This map shows the geographic impact of Falak A. Siddiqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falak A. Siddiqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falak A. Siddiqui more than expected).

Fields of papers citing papers by Falak A. Siddiqui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Falak A. Siddiqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falak A. Siddiqui. The network helps show where Falak A. Siddiqui may publish in the future.

Co-authorship network of co-authors of Falak A. Siddiqui

This figure shows the co-authorship network connecting the top 25 collaborators of Falak A. Siddiqui. A scholar is included among the top collaborators of Falak A. Siddiqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Falak A. Siddiqui. Falak A. Siddiqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zehravi, Mehrukh, et al.. (2025). Clinical insights into the mechanisms of infectious microbes and microbiota in chronic neurologic and psychiatric diseases. Pathology - Research and Practice. 272. 156090–156090. 3 indexed citations
2.
Kale, Mayura, Mehrukh Zehravi, Aziz Unnisa, et al.. (2024). A rapid and large volume synthesis of mono-, di-, tri-, and tetra-substituted imidazole derivatives via ultrasonic radiation-driven technique. Radiation effects and defects in solids. 179(3-4). 431–450. 4 indexed citations
4.
Panigrahi, Kahnu Charan, Sharuk L. Khan, Falak A. Siddiqui, et al.. (2023). Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay. Molecules. 28(3). 1004–1004. 10 indexed citations
5.
Zehravi, Mehrukh, Hitendra S. Mahajan, Sachin Puri, et al.. (2023). Surface decorated quantum dots: Synthesis, properties and role in herbal therapy. Frontiers in Cell and Developmental Biology. 11. 1139671–1139671. 10 indexed citations
6.
Gandla, Kumaraswamy, Aziz Unnisa, Indu Sharma, et al.. (2023). Carotenoids: Role in Neurodegenerative Diseases Remediation. Brain Sciences. 13(3). 457–457. 17 indexed citations
7.
Gandla, Kumaraswamy, Fahadul Islam, Mehrukh Zehravi, et al.. (2023). Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. Heliyon. 9(9). e19454–e19454. 11 indexed citations
8.
Raja, M. K. Mohan Maruga, Mehrukh Zehravi, Rokeya Sultana, et al.. (2023). An overview of polymer surface coated synthetic quantum dots as therapeutics and sensors applications. Progress in Biophysics and Molecular Biology. 184. 1–12. 6 indexed citations
9.
Gandla, Kumaraswamy, P. Rajasulochana, Manoj S. Charde, et al.. (2023). Fluorescent-Nanoparticle-Impregnated Nanocomposite Polymeric Gels for Biosensing and Drug Delivery Applications. Gels. 9(8). 669–669. 13 indexed citations
10.
Haque, M. Akiful, Akash Marathakam, Samar J. Almehmadi, et al.. (2023). Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors. Molecules. 28(2). 501–501. 9 indexed citations
11.
Siddiqui, Falak A., et al.. (2022). overview of oxadiazole-containing compounds as potential antidiabetic agents. International Journal of Health Sciences. 1096–1112. 1 indexed citations
12.
Chauhan, Neha, Sharuk L. Khan, Falak A. Siddiqui, et al.. (2022). Ethosomes: A novel drug carrier. Annals of Medicine and Surgery. 82. 104595–104595. 67 indexed citations
13.
Siddiqui, Falak A., Sharuk L. Khan, Zubair Ahmad, et al.. (2022). Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents. Molecules. 27(18). 6001–6001. 20 indexed citations
15.
Khan, Sharuk L., et al.. (2021). Stability Study of Mucoadhesive Microsphere Containing Nateglinide by Using Biodegradable Polymer Chitosan. Journal of Pharmaceutical Research International. 866–872. 2 indexed citations
16.
Unnisa, Aziz, et al.. (2021). In-silico Inhibitory Potential of Triphala Constituents Against Cytochrome P450 2E1 for the Prevention of Thioacetamide-induced Hepatotoxicity. Journal of Pharmaceutical Research International. 367–375. 9 indexed citations
20.
Khan, Sharuk L. & Falak A. Siddiqui. (2020). Beta-Sitosterol: As Immunostimulant, Antioxidant and Inhibitor of SARS-CoV-2 Spike Glycoprotein. 2(1). 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026